2012-11-23 13:46:26 - Synthetic Biology - A Global Market Report - a new market research report on companiesandmarkets.com

The global Synthetic biology market is projected to exceed $4.5 billion by the year 2015. Synthetic biology is expected to provide major advances in the areas of biomedicine, biopharmaceuticals synthesis, biosecurity, energy and environment, sustainable chemical segment, and biomaterials/smart materials production. Significant investments are expected in the synthetic biology field.

Synthetic biology is an emerging technology, which enables the creation of organisms from a genetic code that is not found in the natural world. The new biological research area integrates science with engineering for designing and building novel biological entities, including cells, genetic circuits and enzymes, or for redesigning active biological systems and living organisms, such as bacteria.

Synthetic Biology is gaining tremendous recognition as a transformative technology that not just has

 

 

the capability to address food shortage and security issues but also tackle other threats such as climate change, water deficit and energy shortages. The market would be driven by growing popularity of synthetic biology in the areas of energy and chemicals, biotechnology and pharmaceuticals, and other potential applications.

Scotland and the UK have made significant strides in the field of synthetic biology, as stated by a new report on Synthetic Biology. However, of late, the market has seen the emergence of several European and Far East countries. Synthetic biology is also gaining popularity in Japan and China.

In terms of research, most of the research in synthetic biology is being pioneered by the US groups; however, a few UK universities (including Cambridge and Imperial College) are also engaged in the work. The research community in Europe is relatively slower in embracing the field. Nevertheless, the EU community possesses enormous expertise that can be tapped in order to develop a European synthetic biology programme. Scotland´s £2.5 million worth Genome Segment Assembly (GSA) programme, expected to offer tremendous opportunity to the country for gaining competitive advantage in the synthetic biology market.

The report titled Synthetic Biology: A Global Market Report provides a review of the synthetic biology market, outlook, opportunities, challenges, drivers, research and developments efforts, invesments, recent corporate developments, and coverage on select market participants. The study analyzes market data and analytics for the global market in terms of dollar sales. Key players analyzed include Amyris Biotechnologies Inc., ATG Biosynthetics GmbH, Blue Heron Biotechnology, Inc., Chromatin Inc., DNA2.0, febit Synbio GmbH, GENEART AG, GenScript USA, Inc., Gevo Inc., LS9 Inc., Solazyme Inc., Sloning BioTechnology GmbH, Synthetic Genomics Inc., Verdezyne Inc.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.